FDA Issues Suicidality Alert On Antiepileptics
A class-wide relabeling is expected, but Pfizer says that Neurontin and Lyrica show no signs of increased events.
A class-wide relabeling is expected, but Pfizer says that Neurontin and Lyrica show no signs of increased events.